FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileTHC Farmaceuticals, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CBDG
THC Farmaceuticals, Inc. Stock AnalysisComprehensive stock analysis for THC Farmaceuticals, Inc. (CBDG) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCBDG
CBDG
THC Farmaceuticals, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CBDG
Home🔹Stocks🔹THC Farmaceuticals, Inc.

THC Farmaceuticals, Inc.

🇺🇸CBDG•OTC

THC Farmaceuticals, Inc.

🇺🇸CBDG•OTC
Market cap
$797.79K
Sentiment

Your view on CBDG

Mkt Cap
$797.79K
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About THC Farmaceuticals, Inc.

Industry
Biotechnology
Sector
Healthcare
CEO
Ed Rosenthal
Headquarters
7170 East McDonald Drive, Scottsdale, AZ, US
Industry
Biotechnology
Sector
Healthcare
CEO
Ed Rosenthal
Headquarters
7170 East McDonald Drive, Scottsdale, AZ, US
Description

THC Farmaceuticals, Inc. owns and operates non-financial institution cash-dispensing automated teller machines at third-party owned retail and commercial locations. The company's machines are placed in hotels, stores, bowling alleys, and other high customer traffic areas for small and medium sized businesses.

As of June 30, 2015, it had a total of eight machines for public use along the Wasatch Front in the State of Utah.

The company was formerly known as City Media, Inc. and changed its name to THC Farmaceuticals, Inc. in February 2015. THC Farmaceuticals, Inc. was founded in 2008 and is based in Scottsdale, Arizona. THC Farmaceuticals, Inc. operates as a subsidiary of Weed Growth Fund, Inc.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

Fair value for THC Farmaceuticals, Inc. from FRC's valuation model, read against the market price. CBDG last traded at $0.04; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for THC Farmaceuticals, Inc.. Starting points for THC Farmaceuticals, Inc.: beta -9.64 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for THC Farmaceuticals, Inc.. THC Farmaceuticals, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for THC Farmaceuticals, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

As of Nov 12, 2026 · USD

Earnings Estimate

EPSCurrent QtrSep 2022Next QtrDec 2022
Avg. estimate$1.27$1.95
Low estimate$1.27$1.95
High estimate$1.27$1.95
No. of analysts11
Year-ago EPS——
Growth——

Revenue Estimate

RevenueCurrent QtrSep 2022Next QtrDec 2022
Avg. estimate$0.00$0.00
Low estimate$0.00$0.00
High estimate$0.00$0.00
No. of analysts00
Year-ago revenue——
Growth——

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 12, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for THC Farmaceuticals, Inc.. THC Farmaceuticals, Inc. has reported as a listed company since 2014. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

THC Farmaceuticals, Inc. valued side by side against its closest peers. THC Farmaceuticals, Inc. is measured against Biotechnology peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

News

Latest headlines and market coverage.

Latest headlines and company announcements for THC Farmaceuticals, Inc.. Coverage tracks THC Farmaceuticals, Inc. within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of THC Farmaceuticals, Inc.

Peer companies

  • CHNXFChitogenX Inc.
  • ENMIDH Enchantment Inc.
  • IPIXInnovation Pharmaceuticals Inc.
  • PFNDPathfinder Cell Therapy, Inc.
  • RASPActavia Life Sciences, Inc.
  • RGBPRegen BioPharma, Inc.
  • SNNCSibannac, Inc.

More Biotechnology companies

  • ASNDAscendis Pharma A/S
  • ASPHFAscentage Pharma Group International
  • ATAIAtai Life Sciences N.V.
  • ATGGFActinogen Medical Limited
  • ATH.AXAlterity Therapeutics Limited
  • ATHEAlterity Therapeutics Limited
  • ATNMActinium Pharmaceuticals, Inc.
  • ATOSAtossa Therapeutics, Inc.
  • ATRAAtara Biotherapeutics, Inc.
  • ATRXAdhera Therapeutics, Inc.
  • ATX.AXAmplia Therapeutics Limited
  • ATXIAvenue Therapeutics, Inc.
CBDG Analysis
Fair
Past5
Growth2
Health5
Profit1
Value1

News

Latest Market News